Only had a quick look so far and cant find anything to link it to ff Kemin on the other hand does have a connection to DSM http://www.sportsnutrition-event.com/kemin-xsurge/ Kemin Human Nutrition and Health division develops high quality science based ingredients with healthful benefits for the dietary supplement and functional food and beverage markets
in relation to our own current GBP 12 million market cap position implying virtually no sales in comparison (simple reason being the powder version not being commercially available until May 2013).
And, unique only to PXS/DSM.
Medical professionals have clearly indicated that platelet aggregation is no less important than cholesterol or blood pressure. 50 million Americans seem to agree by taking LDA (knowing of no natural alternative without side effects - yet).
So - if, or (imho) when a global brand with the marketing budget to inform people why waste your time only dealing with part of the problem takes FF to a mass marketing level, the potential for this share becomes enormous in a market which already exists with 30% of worldwide deaths attributable to CVD, DVT and stroke (and growing - refer to my previous mail re. British Government stats).
In terms of SP uplift, we only need to achieve a fraction of this potential but hopefully much much more. Also refer to my earlier post which extrapolates from known Sirco sales data before their reported 300% increase (the only purpose of this was to illustrate a possible growth pattern based on 40 established products but what if, 80, 120, 200, 300 including globals???).
Just one DSM owned company sells 21 million Omega3 doses per day. No doubt they have the same aspirations for FF the 'Pearl in their Portfolio'. Draw your own conclusions - I have.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.